This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Osteotech, Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovations in Tissue Pathogen Inactivation by Inventor Sheldon Dean
Introduction
Sheldon Dean is an innovative inventor based in Jackson, NJ (US). He holds a patent for a unique process aimed at the inactivation and removal of pathogens from tissue. His work has significant implications for the medical field, particularly in the areas of bone and connective tissue preservation.
Latest Patents
Sheldon Dean's patent focuses on a tissue pathogen inactivation/removal process. This process involves centrifuging bone, such as cortical or cancellous bone, or connective tissue while applying a solution in a continuous manner. The centrifuge generates forces that allow the solution to penetrate the cavities of the tissue effectively. The solution, which may include alcohol, a detergent, an oxidizer, or a surfactant, flushes the cavities and removes viral and bacterial contaminants. In a second embodiment, the process can be performed in a batch mode, where the tissue is first spun dry and then submerged in a cleansing solution. This method utilizes high G forces to ensure thorough cleansing. Additionally, enzymes can be used to digest lipids and proteins, which are then removed with a flushing solution. The centrifuge can also infuse biologically useful materials into the tissue.
Career Highlights
Throughout his career, Sheldon Dean has worked with notable companies in the medical field, including Osteotech, Inc. and Warsaw Orthopedic, Inc. His contributions to these organizations have helped advance the technology surrounding tissue preservation and pathogen removal.
Collaborations
Sheldon Dean has collaborated with professionals such as Lawrence A. Shimp and Daniel Martins. These partnerships have likely enriched his work and contributed to the development of his innovative patent.
Conclusion
Sheldon Dean's contributions to the field of tissue pathogen inactivation represent a significant advancement in medical technology. His innovative processes have the potential to enhance the safety and efficacy of tissue transplantation and preservation.